An International Pulmonary Embolism Registry Using EKOS
NCT ID: NCT03426124
Last Updated: 2023-02-22
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1480 participants
OBSERVATIONAL
2018-03-01
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism
NCT02396758
Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PE
NCT03581877
ULTrasound Accelerated ThrombolysIs of PulMonAry Embolism
NCT01166997
Evaluating the Efficacy, Safety and Long Term Functional Outcomes of Percutaneous Mechanical Aspiration Thrombectomy for Treatment of Acute Pulmonary Embolism Using the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 System
NCT06697314
Assessment of Right Ventricular Function After Acute Pulmonary Embolism Using Speckle Tracking Echocardiography
NCT04609605
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
For the retrospective arm of the registry, the investigators will gather data from consecutive cases of individuals who received the APT treatment for pulmonary embolism. Specific baseline, treatment, and long-term health information is collected and de-identified.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Retrospective
Individuals with intermediate-high or high risk pulmonary embolism who were consecutively treated with the Ekosonic Endovascular System (EKOS) and thrombolytic drug between January 2014 and one year prior to site activation.
EkoSonic Endovascular System with thrombolytic
The device uses ultrasonic waves in combination with clot-dissolving thrombolytic drug to effectively dissolve clots.
Prospective
Individuals who are experiencing intermediate-high or high risk pulmonary embolism where the treating investigator has selected the EKOS device and thrombolytic drug. The duration of ultrasound and volume of thrombolytic drug are selected per physician discretion.
EkoSonic Endovascular System with thrombolytic
The device uses ultrasonic waves in combination with clot-dissolving thrombolytic drug to effectively dissolve clots.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EkoSonic Endovascular System with thrombolytic
The device uses ultrasonic waves in combination with clot-dissolving thrombolytic drug to effectively dissolve clots.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* RV/LV ≥ 1.0 from diagnostic computed tomographic angiography (CTA) or echocardiogram
* PE symptom duration ≤ 14 days
* Troponin elevation
* Male or female ≥ 18 years of age and ≤ 80 years of age
* RV/LV ≥ 1.0 from diagnostic computed tomographic angiography (CTA) or echocardiogram
* PE symptom duration ≤ 14 days
* Troponin elevation
* Signed informed consent obtained from participant or legally authorized representative
* Investigator has selected the EKOS device to treat participant with massive or submassive pulmonary embolism
Exclusion Criteria
* High-risk for catastrophic bleeding
* Life expectancy \< one year
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
BTG International Inc.
OTHER
Boston Scientific Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Keith Sterling, MD
Role: PRINCIPAL_INVESTIGATOR
Inova Alexandria Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Healthfinity, PLLC Advanced Cardiac & Vascular Clinic
Glendale, Arizona, United States
Cedars - Sinai
Los Angeles, California, United States
Radiology Imaging Associates
Englewood, Colorado, United States
Bradenton Cardiology Center
Bradenton, Florida, United States
Delray Medical Center
Delray Beach, Florida, United States
St. Vincent's Healthcare
Jacksonville, Florida, United States
University of Florida
Jacksonville, Florida, United States
Memorial Hospital
Jacksonville, Florida, United States
University of Miami
Miami, Florida, United States
Florida Hospital
Orlando, Florida, United States
Orlando Health, Inc.
Orlando, Florida, United States
Tallahassee Research Institute, Inc
Tallahassee, Florida, United States
AdventHealth Tampa Pepin Heart Institute
Tampa, Florida, United States
Emory University
Atlanta, Georgia, United States
Augusta University
Augusta, Georgia, United States
WellStar Medical Group
Marietta, Georgia, United States
Northwestern University
Chicago, Illinois, United States
Loyola University Medical Center
Maywood, Illinois, United States
St. Mary Medical Center
Hobart, Indiana, United States
St. Vincent Hospital
Indianapolis, Indiana, United States
St. Elizabeth Healthcare
Crestview Hills, Kentucky, United States
University of Kentucky
Lexington, Kentucky, United States
Jewish Hospital
Louisville, Kentucky, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Brigham & Women's Hospital
Boston, Massachusetts, United States
St. Vincent Hospital/Reliant Medical Group
Worcester, Massachusetts, United States
University of Michigan Health System
Ann Arbor, Michigan, United States
Ascension St. John Hospital
Detroit, Michigan, United States
Spectrum Health
Grand Rapids, Michigan, United States
Metro Health - University of Michigan Health
Wyoming, Michigan, United States
Cardiology Associates of Northern Mississippi
Oxford, Mississippi, United States
Saint Louis University Hospital
St Louis, Missouri, United States
Dartmouth - Hitchcock Medical Center
Lebanon, New Hampshire, United States
Cooper University Healthcare
Camden, New Jersey, United States
University of Buffalo
Buffalo, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
East Carolina University
Greenville, North Carolina, United States
Wake Forest Baptist Health
Winston-Salem, North Carolina, United States
Summa Health
Akron, Ohio, United States
Mercy Health Cincinnati
Cincinnati, Ohio, United States
University of Cincinnati
Cincinnati, Ohio, United States
TriHealth Good Samaritan Bethesda North
Cincinnati, Ohio, United States
Ohio State University
Columbus, Ohio, United States
Mount Caramel East Hospital
Columbus, Ohio, United States
University of Toledo
Toledo, Ohio, United States
Genesis Healthcare System
Zanesville, Ohio, United States
Oregon Health & Science University
Portland, Oregon, United States
St. Luke's University Health Network
Bethlehem, Pennsylvania, United States
St. Vincent Hospital, Allegheny Health Network
Erie, Pennsylvania, United States
Temple University Hospital, Department of Thoracic Medicine & Surgery
Philadelphia, Pennsylvania, United States
Allegheny General Hospital
Pittsburgh, Pennsylvania, United States
UPMC Hamot
Pittsburgh, Pennsylvania, United States
Lankenau Medical Center
Wynnewood, Pennsylvania, United States
Lexington Cardiology
West Columbia, South Carolina, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Hendrick Medical Center
Abilene, Texas, United States
The Heart Hospital Baylor Plano
Plano, Texas, United States
Houston Methodist Sugarland
Sugar Land, Texas, United States
Inova Alexandria Hospital
Alexandria, Virginia, United States
Sentara Vascular Specialists
Norfolk, Virginia, United States
Providence Regional Medical Center
Everett, Washington, United States
Inland Imaging
Spokane, Washington, United States
CAMC
Charleston, West Virginia, United States
West Virginia University Heart & Vascular Institute
Morgantown, West Virginia, United States
Aurora Cardiovascular Services
Milwaukee, Wisconsin, United States
Medical University of Vienna
Vienna, , Austria
CHRU jean Minjoz, Pôle cœur-Poumons
Besançon, , France
Hôpital Nord, APHM
Marseille, , France
Johannes Gutenberg Univeristy Mainz
Mainz, , Germany
Technical University Munchen
München, , Germany
University Medical Center Uterecht
Utrecht, , Netherlands
Swiss Cardiovascular Center
Bern, , Switzerland
University Hospital Zurich
Zurich, , Switzerland
Acibadem University School of Medicine
Istanbul, , Turkey (Türkiye)
Royal Devon and Exeter Hospital
Exeter, , United Kingdom
Medway NHS Foundation Trust
Gillingham, , United Kingdom
Oxford University Hospitals
Headington, , United Kingdom
Royal Free
London, , United Kingdom
Guy's & St Thomas' NHS Foundation Trust
London, , United Kingdom
St. Mary's Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sterling KM, Goldhaber SZ, Sharp ASP, Kucher N, Jones N, Maholic R, Meneveau N, Zlotnick D, Sayfo S, Konstantinides SV, Piazza G. Prospective Multicenter International Registry of Ultrasound-Facilitated Catheter-Directed Thrombolysis in Intermediate-High and High-Risk Pulmonary Embolism (KNOCOUT PE). Circ Cardiovasc Interv. 2024 Mar;17(3):e013448. doi: 10.1161/CIRCINTERVENTIONS.123.013448. Epub 2024 Jan 24.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BTG-001653-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.